My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 127

    1.

    Statins research unfinished saga: desirability versus feasibility.

    Fisman EZ, Adler Y, Tenenbaum A.

    Cardiovasc Diabetol. 2005 Jun 7;4(1):8.PMID: 15941471 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Optimal management of combined dyslipidemia: what have we behind statins monotherapy?

    Tenenbaum A, Fisman EZ, Motro M, Adler Y.

    Adv Cardiol. 2008;45:127-53. Review.PMID: 18230960 [PubMed - indexed for MEDLINE]Related articles

    3.

    Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

    Nesto RW.

    Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.PMID: 16259526 [PubMed - indexed for MEDLINE]Related articles

    4.

    Statins for treatment of dyslipidemia in chronic kidney disease.

    Shurraw S, Tonelli M.

    Perit Dial Int. 2006 Sep-Oct;26(5):523-39. Review.PMID: 16973506 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

    Cziraky MJ, Watson KE, Talbert RL.

    J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.PMID: 19891279 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Hyperlipidemia and fibrates with special reference to diabetes]

    Henkel E, Hanefeld M.

    Herz. 2001 Dec;26(8):523-30. German. PMID: 11820155 [PubMed - indexed for MEDLINE]Related articles

    7.

    Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins.

    Tenenbaum A, Fisman EZ, Motro M, Adler Y.

    Cardiovasc Diabetol. 2006 Sep 26;5:20. Review.PMID: 17002798 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A systematic review and economic evaluation of statins for the prevention of coronary events.

    Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

    Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.PMID: 17408535 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.

    Staels B, Maes M, Zambon A.

    Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):542-53. Epub 2008 Jul 15. Review.PMID: 18628776 [PubMed - indexed for MEDLINE]Related articles

    10.

    Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.

    Ascaso J, Gonzalez Santos P, Hernandez Mijares A, Mangas Rojas A, Masana L, Millan J, Pallardo LF, Pedro-Botet J, Perez Jimenez F, Pintó X, Plaza I, Rubiés J, Zúñiga M.

    Am J Cardiovasc Drugs. 2007;7(1):39-58. Review. Erratum in: Am J Cardiovasc Drugs. 2007;7(4):302. PMID: 17355165 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    12.

    Statin treatment and the natural history of atherosclerotic-related diseases: pathogenic mechanisms and the risk-benefit profile.

    Napoli C, Sica V.

    Curr Pharm Des. 2004;10(4):425-32. Review.PMID: 14965203 [PubMed - indexed for MEDLINE]Related articles

    13.

    REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia.

    Ginsberg HN.

    J Clin Endocrinol Metab. 2006 Feb;91(2):383-92. Epub 2005 Nov 15. Review.PMID: 16291700 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Statins for everybody? New evidence on the efficacy and safety of the inhibitors of HMG Co-A reductase.

    Alcocer L.

    Am J Ther. 2003 Nov-Dec;10(6):423-8. Review.PMID: 14624280 [PubMed - indexed for MEDLINE]Related articles

    15.

    Association of dyslipidemia and effects of statins on nonmacrovascular diseases.

    Baghdasarian SB, Jneid H, Hoogwerf BJ.

    Clin Ther. 2004 Mar;26(3):337-51. Review.PMID: 15110128 [PubMed - indexed for MEDLINE]Related articles

    16.

    Myopathy with statin-fibrate combination therapy: clinical considerations.

    Jacobson TA.

    Nat Rev Endocrinol. 2009 Sep;5(9):507-18. Epub 2009 Jul 28. Review.PMID: 19636324 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Favorable effects of decreasing lipids in patients with diabetes mellitus]

    Gouni-Berthold I, Krone W.

    Dtsch Med Wochenschr. 2006 Dec;131 Suppl 8:S252-4. Review. German. PMID: 17139581 [PubMed - indexed for MEDLINE]Related articles

    18.

    Lipid changes and statins in chronic renal insufficiency and dialysis.

    Wanner C, Krane V, Metzger T, Quaschning T.

    J Nephrol. 2001 Nov-Dec;14 Suppl 4:S76-80. Review.PMID: 11798151 [PubMed - indexed for MEDLINE]Related articles

    19.

    Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statins.

    Papadakis JA, Milionis HJ, Press M, Mikhailidis DP.

    J Diabetes Complications. 2001 Jul-Aug;15(4):211-26. Review.PMID: 11457674 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Clinical trials of statins and fibrates --a meta-analysis]

    Stanulović V, Derić M, Popović J.

    Med Pregl. 2006 May-Jun;59(5-6):213-8. Serbian. PMID: 17039901 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk